Acute lung injury

Dail and Hammar's Pulmonary Pathology

Volumn 1, Issue , 2008, Pages 64-83

  Beasley, Mary Beth ^a  

^a PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890138364     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68792-6_4     Document Type: Chapter

References (119)

1. Katzenstein AL. Acute lung injury patterns: Diffuse alveolar damage and bronchiolitis-obliterans-organizing pneu-monia. In: Katzenstein and Askin's surgical pathology of non-neoplastic lung disease. Philadelphia: WB Saunders, 1997:1447.
2. Carmichael LC, Dorinsky PM, Higgins SB, et a1. Diagnosis and therapy of acute respiratory distress syndrome in adults: an international survey. J Crit Care 1996;11(1): 9-18.
3. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312(3):152-158.
4. Davison AG, Heard BE, McAllister WA, Turner-Warwick ME. Cryptogenic organizing pneumonitis. Q J Med 1983; 52(207):382-394.
5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165(2):277-304.
6. Colby TV Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(1 suppl): 38S-43S.
7. Travis WD, Colby T, Koss MN, Rosado de Christiansen ML, Muller NL, King TE Jf. Idiopathic interstitial pneumonia and other diffuse parenchymal lung disease. Nonneoplastic disorders of the lower respiratory tract. Washington, DC: Armed Forces Institute of Pathology, 2004.
8. Myers JL, Colby TV Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse pan bronchiolitis. Clin Chest Med 1993;14(4):611-622.
9. Cordier JF. Organising pneumonia. Thorax 2000;55(4): 318-328.
10. Cordier JF. Cryptogenic organizing pneumonitis. Bronchiolitis obliterans organizing pneumonia. Clin Chest Med 1993;14(4):677-692.
11. King TE Jr, Mortenson RL. Cryptogenic organizing pneumonitis. The North American experience. Chest 1992;102(1 suppl):8S-13S.
12. Muller NL, Staples CA, Miller RR. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. AJR 1990;154(5):983-987.
13. Lee KS, Kullnig P, Hartman TE, Muller NL. Cryptogenic organizing pneumonia: CT findings in 43 patients. AJR 1994;162(3):543-546.
14. Costabel U, Teschler H, Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 1992;5(7):791-797.
15. Kitaichi M. Differential diagnosis of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(1 suppl): 44S-49S.
16. Cohen AJ, King TE Jr, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994;149(6):1670-1675.
17. Yousem SA, Lohr RH, Colby TV Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors. Mod Pathol 1997;10(9):864-871.
18. Allen IN, Wewers MD. HIV-associated bronchiolitis obliterans organizing pneumonia. Chest 1989;96(1):197-198.
19. Carey CF, Mueller L, Fotopoulos CL, Dall L. Bronchiolitis obliterans-organizing pneumonia associated with Cryptococcus neoformans infection. Rev Infect Dis 1991;13(6): 1253-1254.
20. Diehl JL, Gisselbrecht M, Meyer G, Israel-Biet D, Sors H. Bronchiolitis obliterans organizing pneumonia associated with chlamydial infection. Eur Respir J 1996;9(6): 1320-1322.
21. Foley NM, Griffiths MH, Miller RF. Histologically atypical Pneumocystis carinii pneumonia. Thorax 1993;48(10): 996-1001.
22. Goldstein JD, Godleski JJ, Balikian JP, Herman PG. Pathologic patterns of Serratia marcescens pneumonia. Hum Patho 11982;13(5):479-484.
23. Mayock DE, O'Rourke PP, Kapur RP. Bronchiolitis obliterans: a complication of group B streptococcal disease treated with extracorporeal membrane oxygenation. Pediatrics 1993;92(1):157-160.
24. Sato P, Madtes DK, Thorning D, Albert RK. Bronchiolitis obliterans caused by Legionella pneumophila. Chest 1985; 87(6):840-842.
25. Yousem SA, Duncan SR, Griffith BP. Interstitial and airspace granulation tissue reactions in lung transplant recipients. Am J Surg Pathol 1992;16(9):877-884.
26. Miyagawa Y, Nagata N, Shigematsu N. Clinicopathological study of migratory lung infiltrates. Thorax 1991;46(4): 233-238.
27. Camp M, Mehta JB, Whitson M. Bronchiolitis obliterans and Nocardia asteroides infection of the lung. Chest 1987; 92(6):1107-1108.
28. Bridges AJ, Hsu KC, Dias-Arias AA, Chechani V Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumato 11992;19(7):1136-1140.
29. Gammon RB, Bridges TA, al Nezir H, Alexander CB, Kennedy JI Jf. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 1992;102(4):1171-1174.
30. Imasaki T, Yoshii A, Tanaka S, Ogura T, Ishikawa A, Takahashi T. Polymyositis and Sjogren's syndrome associated with bronchiolitis obliterans organizing pneumonia. Intern Med 1996;35(3):231-235.
31. Ippolito JA, Palmer L, Spector S, Kane PB, Gorevic PD. Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Semin Arthritis Rheum 1993;23(1): 70-78.
32. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141(3):727-733.
33. Camus P, Lombard IN, Perrichon M, Piard F, Guerin JC, Thivolet FB et al. Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone. Thorax 1989;44(9):711-715.
34. Camus P, Piard F, Ashcroft T, Gal AA, Colby TV The lung in inflammatory bowel disease. Medicine (Baltimore) 1993; 72(3):151-183.
35. Hamadeh MA,Atkinson J, Smith LJ. Sulfasalazine-induced pulmonary disease. Chest 1992;101(4):1033-1037.
36. Rosenow EC III, Myers JL, Swensen SJ, Pisani RJ. Druginduced pulmonary disease. An update. Chest 1992;102(1): 239-250.
37. Swinburn CR, Jackson GJ, Cobden I, Ashcroft T, Morritt GN, Corris PA. Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 1988;43(9): 735-736.
38. van Laar JM, Holscher HC, van Krieken JH, Stolk J. Bronchiolitis obliterans organizing pneumonia after adjuvant radiotherapy for breast carcinoma. Respir Med 1997;91(4): 241-244.
39. Tenholder MF, Becker GL, Cervoni MI. The myelodysplastic syndrome and bronchiolitis obliterans. Ann Intern Med 1990;112(9):714-715.
40. Watanabe K, Senju S, Wen FQ, Shirakusa T, Maeda F, Yoshida M. Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest 1998;114(6): 1599-1606.
41. Siddiqui MT, Garrity ER, Husain AN. Bronchiolitis obliterans organizing pneumonia-like reactions: a nonspecific response or an atypical form of rejection or infection in lung allograft recipients? Hum Pathol 1996;27(7): 714-719.
42. Mathew P, Bozeman P, Krance RA, Brenner MK, Heslop HE. Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;13(2):221-223.
43. Vner AH, Rozum-Slota B, Katzenstein AL. Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis. A clinicopathologic study of 16 cases. Am J Surg Pathol 1996;20(7):794-801.
44. Domingo JA, Perez-Calvo JI, Carretero JA, Ferrando J, Cay A, Civeira F. Bronchiolitis obliterans organizing pneumonia. An unusual cause of solitary pulmonary nodule. Chest 1993;103(5):1621-1623.
45. Lohr RH, Boland BJ, Douglas WW, et al. Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 1997;157(12): 1323-1329.
46. Tomashefski JF Jf. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000;21(3): 435-466.
47. Katzenstein AL, Myers JL, Prophet WD, Corley LS III, Shin MS. Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986;10(6):373-381.
48. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pat hoi 1994;18(2):136-147.
49. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Patho 2000;24(1):19-33.
50. Coleman A, Colby TV Histologic diagnosis of extrinsic allergic alveolitis. Am J Surg Pathol 1988;12(7):514-518.
51. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am 1 Surg Patho 11991;15(4):315-333.
52. Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Engl 1 Med 1969;280(15): 787-798.
53. lederlinic Pl, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 1988;67(3):154-162.
54. Beasley MB, Franks TJ, Galvin LR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002;126(9): 1064-1070.
55. Gaudin PB, Askin FB, Falk RJ, lennette JC. The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic autoantibodies specific for antiproteinase 3 and anti-myeloperoxidase. Am 1 Clin Pathol 1995;104(1):7-16.
56. Yoshinouchi T, Ohtsuki Y, Kubo K, Shikata Y. Clinicopathological study on two types of cryptogenic organizing pneumonitis. Respir Med 1995;89(4):271-278.
57. Ashbaugh DG, Bigelow DB, Petty TL. Acute Respiratory Distress in Adults. Lancet 1967;2:319-323.
58. Katzenstein AL, Bloor CM, Leibow AA. Diffuse alveolar damage-the role of oxygen, shock, and related factors. A review. Am J Patho 1976;85(1):209-228.
59. Katzenstein AL, Myers LL. Acute interstitial pneumonia. Am J Surg Pat Hoi 1986;10;4:256-267.
60. Hamman L, Rich A. Acute diffuse interstitial fibrosis of the lung. Bull 10hns Hopkins Hosp 1944;74:177.
61. Olson 1, Colby TV, Elliott CG. Hamman-Rich syndrome revisited. Mayo Clin Proc 1990;65(12):1538-1548.
62. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish lP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am 1 Respir Crit Care Med 1995;152(6 pt 1):1818-1824.
63. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334-1349.
64. Hudson LD, Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest\999;116(1 suppl: 74S-82S.
65. Luhr OR, Antonsen K, Karlsson M, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. Am 1 Respir Crit Care Med 1999; 159(6):1849-1861.
66. Milberg lA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. lAMA 1995;273(4):306-309.
67. Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med 2003;31(6):1607-1611.
68. Tagliabue M, Casella TC, Zincone GE, Fumagalli R, Salvini E. CT and chest radiography in the evaluation of adult respiratory distress syndrome. Acta Radiol 1994;35(3): 230-234.
69. Yazdy AM, Tomashefski IF lr, Yagan R, Kleinerman 1. Regional alveolar damage (RAD). A localized counterpart of diffuse alveolar damage. Am J Clin Pathol 1989; 92(1):10-15.
70. Churg A, Golden L, Fligiel S, Hogg LC. Bronchopulmonary dysplasia in the adult. Am Rev Respir Dis 1983;127(1): 117-120.
71. Nash G, Foley FD, Langlinais Pc. Pulmonary interstitial edema and hyaline membranes in adult burn patients. Electron microscopic observations. Hum Patho 11974;5(2): 149-160.
72. Tomashefski IF lr, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am I Pathol 1983; 112(1):112-126.
73. Pratt Pc. Pathology of adult respiratory distress syndrome. Monogr Pat hoI 1978;19:43-57.
74. Tomashefski IF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000;21(3): 435-466.
75. Patel SR, Karmpaliotis D, Ayas NT, et al. The role of openlung biopsy in ARDS. Chest 2004;125(1):197-202.
76. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999;27(2):304-312.
77. Matthay MA, Wiener-Kronish lP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990;142(6 pt 1):1250-1257.
78. Sznajder JI. Strategies to increase alveolar epithelial fluid removal in the injured lung. Am 1 Respir Crit Care Med 1999;160(5 pt 1):1441-1442.
79. Greene KE, Wright lR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am 1 Respir Crit Care Med 1999;160(6):1843-1850.
80. Glauser FL. Fairman RP. The uncertain role of the neutrophil in increased permeability pulmonary edema. Chest 1985;88(4):601-607.
81. Laufe MD, Simon RH, Flint A, Keller lB. Adult respiratory distress syndrome in neutropenic patients. Am 1 Med 1986;80(6):1022-1026.
82. Goodman RB, Strieter RM, Martin DP, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am I Respir Crit Care Med 1996; 154(3 pt 1):602-611.
83. Hasleton PS, Roberts TE. Adult respiratory distress syndrome-an update. Histopathology 1999;34(4):285-294.
84. Martinet Y, Menard 0, Vaillant P, Vignaud 1M, Martinet N. Cytokines in human lung fibrosis. Arch Toxicol Suppl 1996;18:127-139.
85. Pugin 1, Ricou B, Steinberg KP, Suter PM, Martin TR. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am 1 Respir Crit Care Med 1996;153(6 pt 1): 1850-1856.
86. Parsons PE, Moore FA, Moore EE, Ikle DN, Henson PM, Worthen GS. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis 1992;146(3):694-700.
87. Fisher Cl Jr,Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl 1 Med 1996;334(26):1697-1702.
88. Donnelly SC, Haslett C, Reid PT, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997;3(3):320-323.
89. El Gamel A, Awad M, Sim E, et al. Transforming growth factor-beta 1 and lung allograft fibrosis. Eur I Cardiothorac Surg 1998;13(4):424-430.
90. Gunther A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am I Respir Crit Care Med 2000;161(2 pt 1):454-462.
91. Idell S, lames KK, Levin EG, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. I Clin Invest 1989;84(2):695-705.
92. Hayashi T, Stetler-Stevenson WG, Fleming MV, et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am I Patho 11996;149(4):1241-1256.
93. Slutsky AS, Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am I Respir Crit Care Med 1998;157(6 pt 1):1721-1725.
94. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive endexpiratory pressure. Am Rev Respir Dis 1988;137(5): 1159-1164.
95. Tazelaar HD, Linz LJ, Colby TV, Myers LL. Acute eosinophilic pneumonia: Histopathologic findings in nine patients. Am i Respir Crit Care Med 1997;155;1:296-302.
96. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir 12003;22(5):821-826.
97. Travis WD, Colby TV, Lombard C, Carpenter HA. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am I Surg Pathol 1990;14(12):1112-1125.
98. Abel Sl, Finney Sl, Brett Sl, Keogh BF, Morgan Cl, Evans TW. Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 1998; 53(4):292-294.
99. Sloane PI, Gee MH, Gottlieb IE, et al. A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis 1992;146(2): 419-426.
100. Bernard GR, Luce 1M, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl I Med 1987;317(25):1565-1570.
101. Luce 1M, Montgomery AB, Marks ID, Turner I, Metz CA, Murray IF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138(1):62-68.
102. Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl I Med 1996;334(22): 1417-1421.
103. Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998;26(1):15-23.
104. Flick MR, Matthay MA. Pulmonary edema and acute lung injury. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine. 3rd ed. Philadelphia: WB Saunders, 2000: 1575.
105. Schoene RB, Hackett PH, Hornbein TF. High altitude. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine. 3rd ed. Philadelphia: WB Saunders, 2000:19151950.
106. Houston CS. Acute pulmonary edema of high altitude. N Engl J Med 1960;263:478-480.
107. Marticorena E, Tapia FA, Dyer J, et al. Pulmonary edema by ascending to high altitudes. Dis Chest 1964;45: 273-283.
108. Menon ND. High altitude pulmonary edema. N Engl J Med 1965;273:66-73.
109. Hultgren HN, Spickard WB, Hellriegel I, Houston CS. High altitude pulmonary oedema. Medicine (Baltimore) 1961;40:289-313.
110. Heath D, Williams DR. High altitude pulmonary oedema. Man at high altitude. The pathophysiology of acclimatization and adaptation. Edinburgh: Churchill Livingston, 1977:121136.
111. Singh I, Kapila CC, Khanna PK, Nanda RB, Rao BDP. High altitude pulmonary edema. Lancet 1965;191:229-234.
112. Arias-Stella J, Kruger H. Pathology of high altitude pulmonary edema. Arch PathoI 11963; 76: 147.
113. Nayak NC, Roy S, Narayaran TK. Pathologic features of altitude sickness. Am J Pat hoi 1964;45:381-391.
114. Heath D, Moosavi H, Smith P. Ultrastructure of high altitude pulmonary oedema. Thorax 1973;28:694-700.
115. Hanaoka M, Kubo K, Yamazaki Y. Association of high altitude pulmonary edema with the major histocompatibility complex. Circulation 1998;97:1124-1128.
116. Kaminsky DA, Jones K, Schoene RB. Urinary leukotriene E4 levels in high-altitude pulmonary edema. A possible role for inflammation. Chest 1996;11:939-945.
117. Oelz 0, Maggiorini M, Ritter M. Nifedipine for high altitude pulmonary edema. Lancet 1989;2:1241-1244.
118. Colice GL, Matthay MA, Bass E, Matthay RA. Neurogenic pulmonary edema. Am Rev Respir Dis 1984;130: 941-948.
119. Sautter RD, Dreher WH, MacIndoe IH, Myers WO, Magnin GE. Fatal pulmonary edema and pneumonitis after re-expansion of chronic pneumothorax. Chest 1971;60:399-401.